Gold Pharma operates a state-of-the-art API and intermediates manufacturing facility in Atchutapuram, Visakhapatnam, India. Commencing operations in 2022, this facility serves as the manufacturing backbone for the company, featuring multi-capacity reactors, stringent regulatory alignment, and an export-oriented approach. It is seamlessly integrated with CVR Life Sciences’ R&D framework, ensuring a cohesive and efficient development pipeline.